Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bio-Rad Laboratories
(NY:
BIO
)
319.37
+5.95 (+1.90%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bio-Rad Laboratories
< Previous
1
2
3
4
5
6
Next >
Stocks That Hit 52-Week Highs On Tuesday
July 27, 2021
This morning 85 companies set new 52-week highs. Noteworthy Mentions: The largest company by market cap to set a new 52-week high was Alphabet (NASDAQ:GOOG). Intec...
Via
Benzinga
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
July 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc...
Via
Benzinga
Exposures
COVID-19
Bio-Rad and 10x Genomics Announce Settlement to Resolve Multiple Litigations
July 27, 2021
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
July 25, 2021
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start...
Via
Benzinga
Exposures
Product Safety
Bio-Rad to Report Second-Quarter 2021 Financial Results, Thursday, July 29, 2021
July 14, 2021
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Announces Partnership with Seegene for Molecular Diagnostic Testing Products
June 30, 2021
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Launches Its PREvalence ddPCR SARS-CoV-2 Wastewater Quantification Kit for COVID-19 Wastewater Testing
June 21, 2021
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
5 Value Stocks To Watch In The Healthcare Sector
June 14, 2021
What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...
Via
Benzinga
The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test
July 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) Ambrx Biopharma Inc. (NYSE:...
Via
Benzinga
Topics
Product Recall
Exposures
COVID-19
Legal
Product Safety
Bio-Rad to Participate at Jefferies Virtual Healthcare Conference
May 20, 2021
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
5 Value Stocks In The Healthcare Sector
May 10, 2021
What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples...
Via
Benzinga
Bio-Rad Laboratories Inc (BIO) Q1 2021 Earnings Call Transcript
April 30, 2021
BIO earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Bio-Rad Reports First-Quarter 2021 Financial Results
April 29, 2021
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx
April 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:...
Via
Benzinga
A Preview Of Bio-Rad Laboratories's Earnings
April 28, 2021
On Thursday, April 29, Bio-Rad Laboratories (NYSE:BIO) will release its latest earnings report. Here is Benzinga's outlook for the company. What Are Earnings, Net Income, And...
Via
Benzinga
The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx
April 24, 2021
Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:...
Via
Benzinga
Exposures
Product Safety
Bio-Rad to Report First-Quarter 2021 Financial Results, Thursday, April 29, 2021
April 15, 2021
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.